ArticleFrontiers in immunology2014

Systems Biology Strategy Reveals PKCδ is Key for Sensitizing TRAIL-Resistant Human Fibrosarcoma.

Kentaro Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.